NEEDHAM, MA--(Marketwired - September 22, 2016) - Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, announces extended programming for its 8th Annual SCOPE: Summit for Clinical Ops Executives at the Hyatt Regency Miami, FL, January 24-26, 2017.
- Protocol Development, Global Site Selection, Feasibility and Site Management
- Enrollment Planning and Patient Recruitment
- Clinical Trial Forecasting and Budgeting
- Establishing and Outsourcing Strategy
- Implementing Risk-Based Monitoring - Part 1
- Clinical Data Strategy and Analytics
- Managing Late Stage Research and Observational Studies
- Symposium: Managing Precision Trials
- Improving Site-Study Activation and Performance
- Patient Engagement, Enrollment and Retention through Communities and Technology
- Managing Outsourced Clinical Trials
- Implementing Risk-Based Monitoring - Part 2
- Clinical Technology and Innovation
- Leveraging Real World Data for Clinical and Observational Research
- Symposium: Sample, Lab and Diagnostic Services in Clinical Trials
"SCOPE has grown over the past eight years into a must-attend clinical trial innovation and biopharma clin ops leadership gathering with over 1,200 delegates," said Micah Lieberman, CHI's executive conference director. "CHI's primary objective is to build a world-class program for large and small biopharma companies, CROs, tech vendors, sites, and academia so they can overcome clinical operations challenges, get new therapies to patients faster, and meet new partners."
Day One officially starts at 8:20 am on January 24, 2017, with a co-presentation by Katherine Vandebelt, Senior Director of Clinical Innovation; and Janelle Sabo, Senior Group Director of Product Delivery at Eli Lilly and Company. They will present "Bringing Design Thinking into Clinical Trials," which considers how we can re-evaluate our current approach to the planning and management of our studies. The presentation will be followed by an executive panel led by Craig Lipset, Head of Clinical Innovation at Pfizer Inc. The panel will feature thought-leaders from Biogen, Genentech, GSK and Eli Lilly.
Day Two's plenary keynote session starts with our annual Clinical Informatics News' "Best Practices Awards" and then a keynote by Jeremy Sohn, a VP and the Head of Digital Business Development & Licensing at Novartis. Jeremy will present on clinical innovations underway today that seem to be the most successful to date and how we can, as an industry, accelerate meaningful change in the ways we run our trials. The panel following will then focus on how to "Move Digital Health Innovation from PowerPoint to Action."
There are plenty of other highlights as well, including 6 short courses, 18 breakout discussion groups, networking functions, and an exhibit hall with 135 exhibitors. Bioclinica endorsed SCOPE 2017 as a Signature Sponsor. Premier Sponsors include BBK Worldwide, Clinical Ink, Comprehend, DrugDev, inVentive Health, OmniComm Systems, Inc., PAREXEL International Corporation, PRA Health Sciences, and Quintiles.
For more information, visit www.scopesummit.com.
Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, email@example.com.
About Cambridge Healthtech Institute (http://www.healthtech.com)
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation, Bio-IT World, Clinical Informatics News and Diagnostics World.